{"transactions":[{"id":1505070,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T20:07:15.000Z","date":"2024-05-21","kind":"sale","planned":false,"acquired":false,"shares":5630,"price":5.74,"value":32316.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023."}],"balance_after":18595,"source":{"system":"sec-edgar","filing":"0001600620-24-000070","document":"wk-form4_1716408419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000070/wk-form4_1716408419.xml","form_type":"4"}},{"id":1880740,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-23T21:16:00.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":15234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in twelve equal monthly installments commencing on June 19, 2023."}],"balance_after":15234,"derivative":{"exercise_price":10.74,"expiration_date":"2033-05-19","underlying":"Common Stock","underlying_shares":15234},"source":{"system":"sec-edgar","filing":"0001600620-23-000018","document":"wk-form4_1684876541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000018/wk-form4_1684876541.xml","form_type":"4"}},{"id":1880739,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-23T21:16:00.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":false,"shares":8733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date."}],"balance_after":0,"derivative":{"exercise_date":"2023-05-18","underlying":"Common Stock","underlying_shares":8733},"source":{"system":"sec-edgar","filing":"0001600620-23-000018","document":"wk-form4_1684876541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000018/wk-form4_1684876541.xml","form_type":"4"}},{"id":1880738,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:16:00.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":4818,"price":11.26,"value":54250.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":24225,"source":{"system":"sec-edgar","filing":"0001600620-23-000018","document":"wk-form4_1684876541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000018/wk-form4_1684876541.xml","form_type":"4"}},{"id":1880737,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:16:00.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":9310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of the RSUs payable solely in common stock of the Issuer. The shares subject to the RSUs shall vest one year from date of grant."}],"balance_after":29043,"source":{"system":"sec-edgar","filing":"0001600620-23-000018","document":"wk-form4_1684876541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000018/wk-form4_1684876541.xml","form_type":"4"}},{"id":1880736,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:16:00.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":true,"shares":8733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date."}],"balance_after":19733,"source":{"system":"sec-edgar","filing":"0001600620-23-000018","document":"wk-form4_1684876541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000018/wk-form4_1684876541.xml","form_type":"4"}},{"id":2261411,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T20:09:49.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":14612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve equal monthly installments commencing on June 18, 2022."}],"balance_after":14612,"derivative":{"exercise_price":11.45,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":14612},"source":{"system":"sec-edgar","filing":"0001628280-22-015034","document":"wf-form4_165307737333111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022015034/wf-form4_165307737333111.xml","form_type":"4"}},{"id":2261410,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-20T20:09:49.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":8733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."}],"balance_after":8733,"derivative":{"underlying":"Common Shares","underlying_shares":8733},"source":{"system":"sec-edgar","filing":"0001628280-22-015034","document":"wf-form4_165307737333111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022015034/wf-form4_165307737333111.xml","form_type":"4"}},{"id":2337189,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-11T21:05:28.000Z","date":"2022-03-09","kind":"purchase","acquired":true,"shares":5000,"price":10.997,"value":54985.0,"ownership":{"direct":true},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001628280-22-005882","document":"wf-form4_164703270263952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005882/wf-form4_164703270263952.xml","form_type":"4"}},{"id":2665532,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T01:17:39.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":31347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on July 14, 2021."}],"balance_after":31347,"derivative":{"exercise_price":12.86,"expiration_date":"2031-06-14","underlying":"Common Shares","underlying_shares":31347},"source":{"system":"sec-edgar","filing":"0001628280-21-012384","document":"wf-form4_162389264098194.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021012384/wf-form4_162389264098194.xml","form_type":"4"}},{"id":2713934,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T20:17:55.000Z","date":"2021-05-12","kind":"purchase","acquired":true,"shares":1600,"price":11.275,"value":18040.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001628280-21-010163","document":"wf-form4_162093703761728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021010163/wf-form4_162093703761728.xml","form_type":"4"}},{"id":2713933,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T20:17:55.000Z","date":"2021-05-12","kind":"purchase","acquired":true,"shares":1400,"price":11.26,"value":15764.0,"ownership":{"direct":true},"balance_after":4400,"source":{"system":"sec-edgar","filing":"0001628280-21-010163","document":"wf-form4_162093703761728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021010163/wf-form4_162093703761728.xml","form_type":"4"}},{"id":2713932,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T20:17:55.000Z","date":"2021-05-11","kind":"purchase","acquired":true,"shares":1000,"price":11.14,"value":11140.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001628280-21-010163","document":"wf-form4_162093703761728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021010163/wf-form4_162093703761728.xml","form_type":"4"}},{"id":2713931,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":87329,"kind":"person","name":"MacKay-Dunn R. Hector","position":1,"cik":"0001838521","reported_name":"MacKay-Dunn R. Hector","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T20:17:55.000Z","date":"2021-05-11","kind":"purchase","acquired":true,"shares":500,"price":11.17,"value":5585.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001628280-21-010163","document":"wf-form4_162093703761728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021010163/wf-form4_162093703761728.xml","form_type":"4"}}]}